Toripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysis
Sign Up to like & getrecommendations! Published in 2022 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2021-004036
Abstract: Background Mucosal melanoma is an aggressive melanoma subtype with poor response to antiprogrammed cell death-1 (PD-1) monotherapy. Axitinib in combination with toripalimab, a humanized IgG4 mAb against PD-1, showed a promising response rate in patients… read more here.
Keywords: survival; metastatic mucosal; mucosal melanoma; biomarker analysis ... See more keywords
Biomarker Analysis from the Compass Claudication Study – Rivaroxaban for Intermittent Claudication
Sign Up to like & getrecommendations! Published in 2025 at "Clinical and Applied Thrombosis/Hemostasis"
DOI: 10.1177/10760296251372934
Abstract: Introduction A prospective, randomized, multicenter study compared rivaroxaban 2.5 mg twice daily plus aspirin 100 mg once daily against aspirin 100 mg once daily alone in patients with peripheral artery disease and intermittent claudication. The study demonstrated that… read more here.
Keywords: biomarker analysis; claudication; claudication study; intermittent claudication ... See more keywords
Genomic correlates of response to adjuvant trastuzumab (H) and pertuzumab (P) in HER2+ breast cancer (BC): Biomarker analysis of the APHINITY trial.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.1012
Abstract: 1012 Background: We conducted a comprehensive genomic and immune-marker based analysis to identify prognostic and predictive biomarkers beyond clinical parameters (eg nodal status) in the setting of HP-based therapy. Methods: APHINITY, a phase III study,… read more here.
Keywords: biomarker analysis; her2; aphinity; trial ... See more keywords
Genomic landscape of angiosarcoma: A targeted and immunotherapy biomarker analysis of 143 patients.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.11545
Abstract: 11545Background: Targeted therapies for angiosarcoma (AS) patients have limited efficacy. Although significant responses to immunotherapy (IO-therapy) have been observed in cutaneous AS, its effica... read more here.
Keywords: angiosarcoma targeted; biomarker analysis; targeted immunotherapy; landscape angiosarcoma ... See more keywords
Genomic and biomarker analysis of immunotherapy combined with chemotherapy treated for patients with metastatic BTC cancer: A real world study.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.e16373
Abstract: e16373 Background: Biliary tract cancer (BTC) is a heterogeneous group of diseases with dismal prognosis. The TOPAZ-1 phase III trial and KENOTE 966 reported a survival benefit with the immune checkpoint inhibitor (ICI) plus chemotherapy… read more here.
Keywords: oncology; biomarker analysis; group; dcr ... See more keywords
Biomarker Analysis of Formalin-Fixed Paraffin-Embedded Clinical Tissues Using Proteomics
Sign Up to like & getrecommendations! Published in 2023 at "Biomolecules"
DOI: 10.3390/biom13010096
Abstract: The relatively recent developments in mass spectrometry (MS) have provided novel opportunities for this technology to impact modern medicine. One of those opportunities is in biomarker discovery and diagnostics. Key developments in sample preparation have… read more here.
Keywords: formalin fixed; biomarker analysis; ffpe tissues; paraffin embedded ... See more keywords